Novavax Says ‘Substantial Doubt’ Around Its Continuing Operations

Covid-19 vaccine manufacturer Novavax said Tuesday that there is “substantial doubt” about its ability to continue operating through this year. In a quarterly earnings report issued after the market c...

Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.

Pfizer probably did more than any other company to help the world normalize from the pandemic, and it reaped a financial windfall from its twin Covid-19 franchise—the top-selling vaccine and the leadi...

Pfizer CEO: Covid Infections Will Rise. So Will Paxlovid and Vaccine Sales.

Pfizer executives say Wall Street analysts haven’t understood just how powerful a hit the company’s Covid-19 products will take this year. That’s the explanation the company’s chief financial officer,...

China’s Big Comeback Is Just Getting Started. How to Play It.

Talk about a comeback. As China abandons policies that stifled economic growth for the past three years, investors have sent the country’s stocks soaring—up more than 50% since October. The rally migh...

The Fed’s Impossible Choice: Eliminate Jobs or Accept Higher Inflation

Text size The Fed may opt to wait in the first half of 2023 rather than keep raising rates, Sonia Meskin writes. Alex Wong/Getty Images About the author: Sonia Meskin is the head of U.S. Macro at BNY ...

China Is Opening Fast. Don’t Miss the Rebound for Stocks.

Chinese authorities’ abrupt pivot away from zero-Covid policies has been matched by the quick shift in investor sentiment about Chinese stocks from the bearishness of the past year. As the world’s sec...

XPeng stock falls after J.P. Morgan says stop buying

Shares of XPeng Inc. fell Wednesday, after J.P. Morgan backed away from its bullish call on the China-based electric vehicle maker, saying the COVID-related reopening trade has been overdone. Analyst ...

China Is Open Again. 13 Ways to Tap Into Its Recovery Right Now.

Chinese stocks look poised to keep bouncing into the Year of the Rabbit. As authorities peel back some of the last Covid restrictions this weekend and policy makers prioritize reviving the world’s sec...

‘I can no longer be an executive at a high level’: Workers with disabilities, including long COVID, are finding their place as companies become more flexible

Dana Pollard started a new job at the end of 2022, after spending three years recovering from a 2019 stroke. Pollard, 56, lives in Fort Worth, Texas, with his wife. After the stroke, he could not reco...

Alibaba Stock Is Soaring. What’s Driving Its Big Move.

Alibaba stock was on a tear Wednesday amid signs that the tough regulatory landscape for Chinese tech stocks—one of two key headwinds facing the sector—is improving. Progress has put investors on a bu...

Business Disruptions Wane as Some Industries See a Return to Normal

After more than two years of pandemic-related upheaval, businesses in many corners of the economy are seeing their Covid disruptions recede. Supply-chain disruptions have eased. A lack of semiconducto...

Southwest, Tesla, Coinbase, Apple, and More Stock Market Movers Friday

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...

Southwest, Tesla, Alibaba, NIO, and More Stock Market Movers Tuesday

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...

Tesla Shares Head for Worst Year Ever as Elon Musk Focuses on Twitter

Listen to article (2 minutes) Tesla Inc. is on pace for its worst annual stock performance on record as investors bristle at Elon Musk’s Twitter Inc. ownership, as well as declining demand for the car...

BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline

Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA technology and the outlook for a combined flu/COVID vaccine and oncology vaccines tha...

Amazon, Walmart, and Kroger Could Have the Solution to Grocery Deliveries

Shoppers returning to stores in the wake of the Covid-19 pandemic, venture-capital money drying up, and higher labor costs mean the first golden age of food delivery looks to be over. But customers ha...

Apple Is Looking to Move Production Out of China, Report Says

Apple has hastened plans to move part of its production out of China, home to the world’s largest iPhone factory, according to a The Wall Street Journal report citing anonymous sources. The world’s mo...

Apple Makes Plans to Move Production Out of China

In recent weeks, Apple Inc. has accelerated plans to shift some of its production outside China, long the dominant country in the supply chain that built the world’s most valuable company, say people ...

Alibaba stock flies toward best month in 7 years

The U.S.-listed shares of Alibaba Group Holding Ltd. were ending a historically strong month on a high note Wednesday, as the China-based e-commerce giant was swept up in the hope that the country wil...

Why China’s COVID policies are rattling investors again

Investors in China-related assets who had expected a significant easing of COVID curbs were left disappointed this week as the country battles the worst wave of cases since Shanghai’s outbreak earlier...

Apple iPhone wait times have doubled in 4 weeks to 38 days, UBS says

It’s too late to buy an Apple iPhone 14 Pro or Pro Max in time for Christmas, as supply disruptions have caused wait times to double over the past four weeks, according to UBS research. As a result, i...

Alibaba and Other Chinese Stocks Keep Rallying. A Big Risk Is Being Ignored.

Alibaba and other Chinese tech stocks appear to have reversed a brutal two-year slide this month. Investors betting on a rebound may be ignoring the risk of China’s “zero Covid” policies and just how ...

Dow ends nearly 400 points higher as investors await Fed minutes

U.S. stocks ended higher Tuesday as traders gauged the impact of fresh COVID-19 restrictions in China and awaited Wednesday’s minutes from the most recent Federal Reserve meeting. How are stocks are t...

Baidu Beats Revenue Expectations Despite Continued Covid Worries

Baidu on Tuesday became the latest Chinese technology company to report a return to annual growth, as it beat expectations for its third-quarter revenue.  Baidu (ticker: BIDU)—often referred to as Chi...

Markets will shift to a ‘hope’ phase next year, and investors would be wise not to miss it, says Goldman Sachs

Fresh China COVID-19 worries are threatening to nix any preholiday gains for Wall Street, with stocks struggling, oil tumbling and the dollar higher as Monday’s session gets underway. In a shortened w...

Oil futures fall 10% for week as China’s COVID worries darken demand picture

Oil futures logged their second straight weekly declines, pressured as a resurgence of COVID-19 worries clouded the energy demand picture, and broader markets kept eyes on a hawkish Federal Reserve. U...

As Pandemic Aid Dries Up, Businesses Chase Covid Tax Credit

A temporary tax break for small businesses has spawned a cottage industry of advisory firms tapping into federal pandemic aid, raising alarms at the Internal Revenue Service that some claims are going...

Apple Issues iPhone Supply Warning. But the Real Issue Is Demand.

Big Tech just can’t catch a break. After a dismal earnings season, in which Apple was one of the only bright sparks, the tech giant offered up its own bad news Sunday. Apple said Covid restrictions in...

Alibaba and Other Chinese Stocks Are Rallying Again. Why It Doesn’t Make Sense.

Chinese stocks rallied on Monday as investors continued to be optimistic that coronavirus rules would be eased, despite repeated messages from authorities that China would stay the course on “zero Cov...

Pfizer’s Earnings Are Tuesday. What to Watch.

Pfizer is set to report its earnings on Tuesday, a week and a half after an executive told investors that the company was considering a list price for its Covid-19 vaccine of between $110 and $130 per...

An American Helped Build a Business Inside China. Clients Want Him to Leave.

It took Jacob Rothman two decades to build a Chinese manufacturing business with his friends and family. Now the 49-year-old American executive says customers want him to make some of his grilling too...

Why investors are fleeing Chinese assets as Xi tightens grip on power

China’s top leader, Xi Jinping, secured a groundbreaking third leadership term on Sunday and introduced a new Politburo Standing Committee stacked with loyalists in a clean sweep not seen since the er...